0001140361-16-080886.txt : 20160928 0001140361-16-080886.hdr.sgml : 20160928 20160928124751 ACCESSION NUMBER: 0001140361-16-080886 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160926 FILED AS OF DATE: 20160928 DATE AS OF CHANGE: 20160928 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DURECT CORP CENTRAL INDEX KEY: 0001082038 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943297098 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10240 BUBB RD CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: 4087771417 MAIL ADDRESS: STREET 1: 10240 BUBB ROAD CITY: CUPERTINO STATE: CA ZIP: 95014 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: 21 APRIL FUND, L.P. CENTRAL INDEX KEY: 0001459688 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31615 FILM NUMBER: 161906407 BUSINESS ADDRESS: STREET 1: FIRST EAGLE INVESTMENT MANAGEMENT, LLC STREET 2: 1345 AVENUE OF THE AMERICAS, 44TH FLOOR CITY: New York STATE: NY ZIP: 10105 BUSINESS PHONE: 212-698-3101 MAIL ADDRESS: STREET 1: FIRST EAGLE INVESTMENT MANAGEMENT, LLC STREET 2: 1345 AVENUE OF THE AMERICAS, 44TH FLOOR CITY: New York STATE: NY ZIP: 10105 FORMER NAME: FORMER CONFORMED NAME: 21 APRIL FUND LP DATE OF NAME CHANGE: 20090325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: First Eagle Holdings, Inc. CENTRAL INDEX KEY: 0001637141 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31615 FILM NUMBER: 161906408 BUSINESS ADDRESS: STREET 1: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 BUSINESS PHONE: 212-698-3300 MAIL ADDRESS: STREET 1: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 FORMER NAME: FORMER CONFORMED NAME: Arnhold & S. Bleichroeder Holdings, Inc. DATE OF NAME CHANGE: 20150319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: First Eagle Value in Biotechnology Master Fund, Ltd. CENTRAL INDEX KEY: 0001457518 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31615 FILM NUMBER: 161906409 BUSINESS ADDRESS: STREET 1: C/O ASB ADVISERS, LLC, GENERAL COUNSEL STREET 2: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 BUSINESS PHONE: 1 212- 698-3000 MAIL ADDRESS: STREET 1: C/O ASB ADVISERS, LLC, GENERAL COUNSEL STREET 2: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: 21 APRIL FUND, LTD. CENTRAL INDEX KEY: 0001459708 STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31615 FILM NUMBER: 161906410 BUSINESS ADDRESS: STREET 1: Citco Fund Services (Cayman Islands) Ltd STREET 2: Regatta Office Park West Bay Road CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1205 BUSINESS PHONE: 345-949-3977 MAIL ADDRESS: STREET 1: Citco Fund Services (Cayman Islands) Ltd STREET 2: Regatta Office Park West Bay Road CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1205 FORMER NAME: FORMER CONFORMED NAME: 21 APRIL FUND LTD DATE OF NAME CHANGE: 20090325 4 1 doc1.xml FORM 4 X0306 4 2016-09-26 0 0001082038 DURECT CORP DRRX 0001459708 21 APRIL FUND, LTD. CITCO FUND SERVICES (CAYMAN ISLANDS) LTD REGATTA OFFICE PARK WEST BAY ROAD GRAND CAYMAN E9 KY1-1205 CAYMAN ISLANDS 0 0 1 0 0001459688 21 APRIL FUND, L.P. FIRST EAGLE INVESTMENT MANAGEMENT, LLC 1345 AVENUE OF THE AMERICAS, 44TH FLOOR NEW YORK NY 10105 0 0 1 0 0001457518 First Eagle Value in Biotechnology Master Fund, Ltd. CITCO FUND SERVICES (CAYMAN ISLANDS) LTD REGATTA OFFICE PARK WEST BAY ROAD GRAND CAYMAN E9 KY1-1205 CAYMAN ISLANDS 0 0 1 0 0001637141 First Eagle Holdings, Inc. 1345 AVENUE OF THE AMERICAS NEW YORK NY 10105 0 0 1 0 Common Stock 2016-09-26 4 P 0 1981224 1.16 A 21862770 D Common Stock 2016-09-26 4 P 0 318776 1.10 A 22181546 D Common Stock 2016-09-26 4 P 0 200000 1.15 A 22381546 D Represents 259,957 and 1,721,267 shares purchased by 21 April Fund, LP ("21 April LP") and 21 April Fund, Ltd. ("21 April Ltd."), respectively. First Eagle Investment Management, LLC ("FEIM") is (i) a general partner of 21 April LP, (ii) the registered investment adviser to First Eagle Value in Biotechnology Master Fund, Ltd. "FEVIBM" as well as to 21 April LP and 21 April Ltd. (collectively, the "Funds") and (iii) a subsidiary of First Eagle Holdings, Inc. ("FEHI"). FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities. Represents 3,322,406, 12,953,420, and 5,586,944 shares held directly by 21 April LP, 21 April Ltd. and FEVIBM, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities. Represents 63,678 and 255,098 shares purchased by 21 April LP and 21 April Ltd., respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities. Represents 3,386,084, 13,208,518, and 5,586,944 shares held directly by 21 April LP, 21 April Ltd. and FEVIBM, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities. Represents 40,809 and 159,191 shares purchased by 21 April LP and 21 April Ltd., respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities. Represents 3,426,893, 13,367,709, and 5,586,944 shares held directly by 21 April LP, 21 April Ltd. and FEVIBM, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities. FIRST EAGLE INVESTMENT MANAGEMENT, LLC, as General Partner of 21 April LP and Investment Adviser of 21 April Ltd. and FEVIBM, By: /s/ Michael M. Kellen, Director 2016-09-28 FIRST EAGLE HOLDINGS, INC., By: /s/ Michael M. Kellen, Director 2016-09-28